Want to join the conversation?
$CBM agreed to buy privately-owned PharmaCore, which specializes in developing, manufacturing and scaling up small molecule Active Pharmaceutical Ingredients (APIs) for clinical phase projects, for about $25MM. $CBM expects deal, net of deal fees, to have neutral impact on EPS in 2016 and to be accretive in 2017. The deal will close within 30 days.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.